CPT code 52443 denotes an endoscopic prostate procedure that combines cystoscopic evaluation, mechanical widening of the anterior commissure of the prostate with a non‑drug‑coated balloon catheter, and targeted intraprostatic drug delivery via a separate drug‑coated balloon catheter, with imaging guidance included. This hybrid procedural code reflects evolving minimally invasive approaches to treating prostate outlet obstruction and delivering focal intraprostatic therapy, and its use has implications for surgical practice patterns and payer coverage decisions nationwide. Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will learn the clinical context for the procedure, the types of sites where the service is typically provided, and which major payers cover the service. The publication summarizes typical billing and service-line considerations, highlights coding relationships, and outlines where input was not available. Data not available in the input is explicitly indicated where applicable. The goal is to give clinicians, coding professionals, and policy analysts a concise reference to understand what CPT code 52443 represents and the payer landscape to consider for authorization and reimbursement planning.